Fangzhou Inc. was awarded the “Social Responsibility Golden Bull Award” at the 2025 Xiamen Industry Development Conference and Listed Companies Golden Bull Awards Ceremony. The company stood out for its revenue growth, profitability, technological innovation, and social value creation in the field of AI-driven chronic disease management. Fangzhou is a leading online chronic disease management platform in China, serving millions of users and physicians. The company continues to advance its AI-powered healthcare solutions and strengthen its leadership position in the industry.

The award comes as China’s National Health Commission promotes the application of AI in healthcare as a key national priority. Fangzhou has established various initiatives to enhance disease management through AI technology, including partnerships with government institutions and pharmaceutical companies. The company is committed to responsible AI governance and compliance with national standards for AI-enabled healthcare solutions. Fangzhou’s focus on AI-driven chronic disease management is driving the industry’s development in China.

Read more at GlobeNewswire: Fangzhou Awarded “Golden Bull Award” for Leadership in